These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. The future of respiratory syncytial virus vaccine development. Polack FP; Karron RA Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S65-73. PubMed ID: 14730272 [TBL] [Abstract][Full Text] [Related]
31. Optimization of plasmid-only rescue of highly attenuated and temperature-sensitive respiratory syncytial virus (RSV) vaccine candidates for human trials. Kaur J; Tang RS; Spaete RR; Schickli JH J Virol Methods; 2008 Nov; 153(2):196-202. PubMed ID: 18722472 [TBL] [Abstract][Full Text] [Related]
32. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS Virol J; 2005 Feb; 2():3. PubMed ID: 15701174 [TBL] [Abstract][Full Text] [Related]
33. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914 [TBL] [Abstract][Full Text] [Related]
34. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma. Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574 [TBL] [Abstract][Full Text] [Related]
35. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Moore ML; Peebles RS Pharmacol Ther; 2006 Nov; 112(2):405-24. PubMed ID: 16820210 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles. Harcourt JL; Anderson LJ; Sullender W; Tripp RA Vaccine; 2004 Jun; 22(17-18):2248-60. PubMed ID: 15149784 [TBL] [Abstract][Full Text] [Related]
37. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. Karron RA; Wright PF; Belshe RB; Thumar B; Casey R; Newman F; Polack FP; Randolph VB; Deatly A; Hackell J; Gruber W; Murphy BR; Collins PL J Infect Dis; 2005 Apr; 191(7):1093-104. PubMed ID: 15747245 [TBL] [Abstract][Full Text] [Related]